Skip to content

In the BioHarmony Drug Report Database

Nafcillin

Nallpen, Unipen (nafcillin) is a small molecule pharmaceutical. Nafcillin was first approved as Nallpen on 1982-01-01. It is used to treat bacterial endocarditis, bacterial infections, bacterial meningitis, bacterial skin diseases, and cellulitis amongst others in the USA.
Trade Name Nallpen, Unipen
Common Name Nafcillin
Indication bacterial endocarditis, bacterial infections, bacterial meningitis, bacterial skin diseases, cellulitis, osteomyelitis, postoperative complications, respiratory tract infections, staphylococcal infections, urinary tract infections, wound infection
Drug Class Penicillins
Nafcillin
Get full access now